Overview

Study on the Effect of Rosuvastatin Treatment on the Prevention of Thrombosis in Patients With Previous Thrombosis

Status:
Withdrawn
Trial end date:
2013-03-01
Target enrollment:
0
Participant gender:
All
Summary
This study evaluates whether treatment with rosuvastatin on top of standard anti-coagulant treatment will decrease the risk of recurrent venous thromboembolism and arterial thromboembolic events in patients with previous deep vein thrombosis or pulmonary embolism.
Phase:
Phase 3
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
AstraZeneca
Treatments:
Rosuvastatin Calcium
Criteria
Inclusion Criteria:

- Signed informed Consent.

- Patients with venous thromboembolism who are treated with anti-coagulant according to
the current guidelines

Exclusion Criteria:

- Patients in need of or already treated with lipid lowering drugs

- Active liver or kidney disease or dysfunction or muscle disorders

- Unstable medical or psychological condition that interferes with study participation

- Pregnant woman or woman with childbearing potential who are not willing to use
contraception

- History of statin-related muscular pain, or hypersensitivity to statins